[1]
Đỗ H. . Kiên and N. V. . Tài, “31. Survival outcomes and prognostic factors of paclitaxel - carboplatin chemotherapy for the treatment of metastatic non-small cell lung cancer acquired resisted to first- and second-generations of EGFR tyrosine kinase inhibitors”, TCNCYH, vol. 160, no. 12V2, pp. 266-274, Jan. 2023.